Management of Adverse Events and Other Practical Considerations in Patients Receiving Capecitabine (Xeloda)
January 2004
in “
European journal of oncology nursing
”
Studysummary In patients undergoing treatment with capecitabine for colon cancer and metastatic breast cancer, this study observed that hand-foot syndrome occurred more frequently than with intravenous 5-FU, but other side effects were less common.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on ejoncologynursing.com →